Applications of omics approaches to the development of microbiological risk assessment using RNA virus dose–response models as a case study

P. Gale, A. Hill, L. Kelly, J. Bassett, P. McClure, Y. Le Mark, I. Soumpasis

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The last decade has seen a huge increase in the amount of “omics” data available and in our ability to interpret those data. The aim of this paper is to consider how omics techniques can be used to improve and refine microbiological risk assessment, using dose response models for RNA viruses, with particular reference to norovirus through the oral route as the case study. The dose response model for initial infection in the gastrointestinal tract is broken down into the component steps at the molecular level and the feasibility of assigning probabilities to each step assessed. The molecular mechanisms are not sufficiently well understood at present to enable quantitative estimation of probabilities on the basis of omics data. At present, the great strength of gene sequence data appears to be in giving information on the distribution and proportion of susceptible genotypes (for example due to the presence of the appropriate pathogen-binding receptor) in the host population rather than in predicting specificities from the amino acid sequences concurrently obtained. The nature of the mutant spectrum in RNA viruses greatly complicates the application of omics approaches to development of mechanistic dose response models and prevents prediction of risks of disease progression (given infection has occurred) at the level of the individual host. However, molecular markers in the host and virus may enable more broad predictions to be made about the consequences of exposure in a population. In an alternative approach, comparing the results of deep sequencing of RNA viruses in the faeces/vomitus from donor humans with those from their infected recipients may enable direct estimates of the average probability of infection per virion to be made.
LanguageEnglish
Pages1537-1548
Number of pages12
JournalJournal of Applied Microbiology
Volume117
Issue number6
Early online date4 Nov 2014
DOIs
Publication statusPublished - 31 Dec 2014

Fingerprint

RNA Viruses
Infection
Norovirus
High-Throughput Nucleotide Sequencing
Information Dissemination
Feces
Virion
Population
Disease Progression
Gastrointestinal Tract
Amino Acid Sequence
Genotype
Viruses
Genes

Keywords

  • infection
  • omics
  • norovirus
  • genetic susceptibility
  • dose response

Cite this

Gale, P. ; Hill, A. ; Kelly, L. ; Bassett, J. ; McClure, P. ; Le Mark, Y. ; Soumpasis, I. / Applications of omics approaches to the development of microbiological risk assessment using RNA virus dose–response models as a case study. In: Journal of Applied Microbiology. 2014 ; Vol. 117, No. 6. pp. 1537-1548.
@article{4cd4ba6a50f84b8482ed19538ba5ec96,
title = "Applications of omics approaches to the development of microbiological risk assessment using RNA virus dose–response models as a case study",
abstract = "The last decade has seen a huge increase in the amount of “omics” data available and in our ability to interpret those data. The aim of this paper is to consider how omics techniques can be used to improve and refine microbiological risk assessment, using dose response models for RNA viruses, with particular reference to norovirus through the oral route as the case study. The dose response model for initial infection in the gastrointestinal tract is broken down into the component steps at the molecular level and the feasibility of assigning probabilities to each step assessed. The molecular mechanisms are not sufficiently well understood at present to enable quantitative estimation of probabilities on the basis of omics data. At present, the great strength of gene sequence data appears to be in giving information on the distribution and proportion of susceptible genotypes (for example due to the presence of the appropriate pathogen-binding receptor) in the host population rather than in predicting specificities from the amino acid sequences concurrently obtained. The nature of the mutant spectrum in RNA viruses greatly complicates the application of omics approaches to development of mechanistic dose response models and prevents prediction of risks of disease progression (given infection has occurred) at the level of the individual host. However, molecular markers in the host and virus may enable more broad predictions to be made about the consequences of exposure in a population. In an alternative approach, comparing the results of deep sequencing of RNA viruses in the faeces/vomitus from donor humans with those from their infected recipients may enable direct estimates of the average probability of infection per virion to be made.",
keywords = "infection, omics, norovirus, genetic susceptibility, dose response",
author = "P. Gale and A. Hill and L. Kelly and J. Bassett and P. McClure and {Le Mark}, Y. and I. Soumpasis",
year = "2014",
month = "12",
day = "31",
doi = "10.1111/jam.12656",
language = "English",
volume = "117",
pages = "1537--1548",
journal = "Journal of Applied Microbiology",
issn = "1364-5072",
number = "6",

}

Applications of omics approaches to the development of microbiological risk assessment using RNA virus dose–response models as a case study. / Gale, P.; Hill, A.; Kelly, L.; Bassett, J.; McClure, P.; Le Mark, Y.; Soumpasis, I.

In: Journal of Applied Microbiology, Vol. 117, No. 6, 31.12.2014, p. 1537-1548.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Applications of omics approaches to the development of microbiological risk assessment using RNA virus dose–response models as a case study

AU - Gale, P.

AU - Hill, A.

AU - Kelly, L.

AU - Bassett, J.

AU - McClure, P.

AU - Le Mark, Y.

AU - Soumpasis, I.

PY - 2014/12/31

Y1 - 2014/12/31

N2 - The last decade has seen a huge increase in the amount of “omics” data available and in our ability to interpret those data. The aim of this paper is to consider how omics techniques can be used to improve and refine microbiological risk assessment, using dose response models for RNA viruses, with particular reference to norovirus through the oral route as the case study. The dose response model for initial infection in the gastrointestinal tract is broken down into the component steps at the molecular level and the feasibility of assigning probabilities to each step assessed. The molecular mechanisms are not sufficiently well understood at present to enable quantitative estimation of probabilities on the basis of omics data. At present, the great strength of gene sequence data appears to be in giving information on the distribution and proportion of susceptible genotypes (for example due to the presence of the appropriate pathogen-binding receptor) in the host population rather than in predicting specificities from the amino acid sequences concurrently obtained. The nature of the mutant spectrum in RNA viruses greatly complicates the application of omics approaches to development of mechanistic dose response models and prevents prediction of risks of disease progression (given infection has occurred) at the level of the individual host. However, molecular markers in the host and virus may enable more broad predictions to be made about the consequences of exposure in a population. In an alternative approach, comparing the results of deep sequencing of RNA viruses in the faeces/vomitus from donor humans with those from their infected recipients may enable direct estimates of the average probability of infection per virion to be made.

AB - The last decade has seen a huge increase in the amount of “omics” data available and in our ability to interpret those data. The aim of this paper is to consider how omics techniques can be used to improve and refine microbiological risk assessment, using dose response models for RNA viruses, with particular reference to norovirus through the oral route as the case study. The dose response model for initial infection in the gastrointestinal tract is broken down into the component steps at the molecular level and the feasibility of assigning probabilities to each step assessed. The molecular mechanisms are not sufficiently well understood at present to enable quantitative estimation of probabilities on the basis of omics data. At present, the great strength of gene sequence data appears to be in giving information on the distribution and proportion of susceptible genotypes (for example due to the presence of the appropriate pathogen-binding receptor) in the host population rather than in predicting specificities from the amino acid sequences concurrently obtained. The nature of the mutant spectrum in RNA viruses greatly complicates the application of omics approaches to development of mechanistic dose response models and prevents prediction of risks of disease progression (given infection has occurred) at the level of the individual host. However, molecular markers in the host and virus may enable more broad predictions to be made about the consequences of exposure in a population. In an alternative approach, comparing the results of deep sequencing of RNA viruses in the faeces/vomitus from donor humans with those from their infected recipients may enable direct estimates of the average probability of infection per virion to be made.

KW - infection

KW - omics

KW - norovirus

KW - genetic susceptibility

KW - dose response

U2 - 10.1111/jam.12656

DO - 10.1111/jam.12656

M3 - Article

VL - 117

SP - 1537

EP - 1548

JO - Journal of Applied Microbiology

T2 - Journal of Applied Microbiology

JF - Journal of Applied Microbiology

SN - 1364-5072

IS - 6

ER -